On 18 October 2011, the EU Court of Justice passed a historic judgment on the patenting of projects that involved stem cells obtained from human embryos, which would then be destroyed.  The ruling would have far-fetching repercussion on the already controversial aspect of obtaining and utilizing stem cell for research and therapeutic use. The ruling, the Court indicated would apply to all the countries that form the European Union.